The University of Vermont College of Medicine has been chosen as the single participating academic medical center in the nation to collaborate with the Navy Medical Research Center (NMRC) and Denmark-based ACE BioSciences in the development and evaluation of a new vaccine against one of the most common food-borne bacteria, Campylobacter. Campylobacter infections account for more than two million cases of food-borne illness and up to 100 deaths in the United States each year, as well as $1.5 to 1.8 billion in lost productivity.
Is there a point at which we give too many vaccines? Should we instead be looking for a better way to help the body reject inimical bacteria?
Leave a comment